Connection
Jennifer Diamond to Aromatase Inhibitors
This is a "connection" page, showing publications Jennifer Diamond has written about Aromatase Inhibitors.
|
|
Connection Strength |
|
|
|
|
|
0.327 |
|
|
|
-
Weiss J, Afghahi A, Shagisultanova E, Diamond JR. Approaching Use of CDK4/6 Inhibitors in Metastatic HR+, HER2- Breast Cancer. Oncology (Williston Park). 2018 Oct 15; 32(10):513-5.
Score: 0.166
-
Stoen E, Kabos P, Borden KC, Brown RJ, Borges VF, Diamond JR. A 35-Year-Old Woman With a Change in HER2 Expression Following Neoadjuvant Chemotherapy for Invasive Breast Cancer. Oncology (Williston Park). 2018 06; 32(6):298-302.
Score: 0.161